|
Market Cap (5-Jun) $614,880,256 (796th) |
Close (30-Jun) $0.330 |
Volume (30-Jun) 147,149 |
Shortsold (26-May) 152,126 (0.04%) (509th) |
|
52w High $2.25 |
52w Low $1.15 |
P/E - |
EPS -0.11 |
IMR released this announcement to the ASX on 4 January 2022, 8:28. The announcement is marked as price sensitive, and is 3 page(s) in length and 154.69kb in size.
You can view all announcements from IMR and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMR was 0.069% short sold according to ASIC data. It was ranked the 494th most shorted stock on the ASX. It remains ranked 509th as of the latest reported data (26 May 2026).
| Other Recent Announcements from IMR | |
|---|---|
| Notification of cessation of securities - IMR | 9 June 2023, 11:34 |
| Appendix 3Y - SW | 7 June 2023, 11:12 |
| Notification regarding unquoted securities - IMR | 6 June 2023, 9:36 |
| Imricor Adds Fourteenth Site and First in Greece | 4 January 2022, 8:28 |
| Imricor Enrolls Two More Sites in Berlin | 24 December 2021, 9:16 |
| Strategic Investment in MiRTLE Medical | 29 November 2021, 9:12 |
| Application for FDA Investigational Device Exemption | 24 November 2021, 10:51 |
You must be logged in to post a reply.
Imricor Medical Systems, Inc 